NCT04949035

Brief Summary

The current SARS-CoV-2 virus pandemic has already affected the lives of every person on earth. Most of the information given in the media on a daily basis focuses on the pandemic aspects. Fear of getting sick arises in the population, and once infection occurs, numerous concerns arise over the course of the disease. For some patients, hospitalization and subsequent rehabilitation is needed due to complications from the disease. Besides the aspect of treating patients physically from the disease, the psychological aspects that often accompany patients during and after the disease are not addressed. Depressive and anxiety symptoms can follow patients for many years and can affect their quality of life. Thus, the purpose of this project is to assess the mental status of patients prior to the inpatient rehabilitation program

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
147

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2021

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2021

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

July 1, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 2, 2021

Completed
Last Updated

August 9, 2021

Status Verified

August 1, 2021

Enrollment Period

3 months

First QC Date

July 1, 2021

Last Update Submit

August 1, 2021

Conditions

Keywords

quality of lifeHADSrehabilitationanxiety

Outcome Measures

Primary Outcomes (3)

  • Hospital Anxiety and Depression Scale (HADS)

    The Hospital Anxiety and Depression Scale (HADS) is a fourteen-item scale scoring from 0 to 3 for each item. The first seven items relate to anxiety (HADS-A), and the remaining seven items relate to depression (HADS-D). The global scoring ranges from 0 to 42 with a cut-off point of 8/21 for anxiety and 8/21 for depression. The higher the score, the greater anxiety or depression symptoms. HADS will be performed at the beginning and after four weeks of treatment.

    15 minutes

  • Perceived stress scale (PSS-10)

    The Perceived Stress Scale (PSS) is the most widely used psychological instrument for measuring the perception of stress. It is a measure of the degree to which situations in one's life are appraised as stressful. Items were designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives.

    15 minutes

  • WHOQOL-BREF

    The WHOQOL-BREF is a shorter version of the WHOQOL-100. Both were developed by the World Health Organisation (WHO) and published in 1995. It was developed over several years and from 15 centres around the world. The questions stem from multiple statements about quality of life, health and well-being from people with and without disease, and health professionals. It has been tested for reliability and validity. The WHOQOL-BREF is a self-administered questionnaire comprising 26 questions on the individual's perceptions of their health and well-being over the previous two weeks. Responses to questions are on a 1-5 Likert scale where 1 represents "disagree" or "not at all" and 5 represents "completely agree" or "extremely".

    10 minutes

Secondary Outcomes (2)

  • Six-Minute Walk Test (6MWT)

    10 minutes

  • Spirometry Test

    20 minutes

Study Arms (1)

COVID-19 survivors

Diagnostic Test: Assessment of mental state and quality of life

Interventions

Patients qualified for rehabilitation will be assessed for stress levels as well as symptoms of anxiety and depression and quality of life before rehabilitation began

COVID-19 survivors

Eligibility Criteria

Age30 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

COVID-19 caused by SARS-CoV-2 has led to a global public health crisis. Clinical symptoms of patients with COVID-19 infection include fever, sore throat, coughing, fatigue, or gastrointestinal infections, which can appear in a smaller population of patients. In more severe cases, respiratory failure symptoms, as well as heart and kidney damage, may occur. This can happen especially in the elderly and in people with other concomitant chronic diseases. Furthermore, the COVID-19 pandemic gives rise to new psychosocial and emotional stressors for recovering patients, including social isolation, physical distancing, loss of employment and uncertainties about the future. Remarkably, many mental problems will continue long after the pandemic is over, some of which will only begin to emerge in the near future.

You may qualify if:

  • Previously hospitalized for SARS-CoV-2 infection;
  • Pulmonary rehabilitation conducted in ward settings

You may not qualify if:

  • Inability to self-complete the research questionnaires;
  • Presence of the following issues at the time of the examination or in the medical data: disturbances of consciousness, psychotic symptoms or other serious psychiatric disorders
  • Initiation of psychiatric treatment during the research project;
  • Patient's refusal at any stage of the research project.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ministry of the Interior and Administration Hospital

Głuchołazy, 48-340, Poland

Location

MeSH Terms

Conditions

COVID-19Anxiety Disorders

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesMental Disorders

Study Officials

  • Joanna Szczepańska-Gieracha, Prof

    University School of Physical Education, Department of Physiotherapy, Wroclaw, Poland

    STUDY DIRECTOR
  • Sebastian Rutkowski, PhD

    The Opole University of Technology, Opole, Poland

    STUDY CHAIR
  • Patryk Szary, MSc

    University School of Physical Education, Department of Physiotherapy, Wroclaw, Poland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 1, 2021

First Posted

July 2, 2021

Study Start

March 1, 2021

Primary Completion

May 28, 2021

Study Completion

June 7, 2021

Last Updated

August 9, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations